ArticleGenome medicine2020

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival.

Mary A Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.